Literature DB >> 16919435

Integrin-regulated FAK-Src signaling in normal and cancer cells.

Satyajit K Mitra1, David D Schlaepfer.   

Abstract

Integrins can alter cellular behavior through the recruitment and activation of signaling proteins such as non-receptor tyrosine kinases including focal adhesion kinase (FAK) and c-Src that form a dual kinase complex. The FAK-Src complex binds to and can phosphorylate various adaptor proteins such as p130Cas and paxillin. In normal cells, multiple integrin-regulated linkages exist to activate FAK or Src. Activated FAK-Src functions to promote cell motility, cell cycle progression and cell survival. Recent studies have found that the FAK-Src complex is activated in many tumor cells and generates signals leading to tumor growth and metastasis. As both FAK and Src catalytic activities are important in promoting VEGF-associated tumor angiogenesis and protease-associated tumor metastasis, support is growing that FAK and Src may be therapeutically relevant targets in the inhibition of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919435     DOI: 10.1016/j.ceb.2006.08.011

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  667 in total

Review 1.  Pathway inhibition: emerging molecular targets for treating glioblastoma.

Authors:  Wolfgang Wick; Michael Weller; Markus Weiler; Tracy Batchelor; Alfred W K Yung; Michael Platten
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  Focal adhesion kinase inhibitors are potent anti-angiogenic agents.

Authors:  Miguel A Cabrita; Laura M Jones; Jennifer L Quizi; Luc A Sabourin; Bruce C McKay; Christina L Addison
Journal:  Mol Oncol       Date:  2011-10-20       Impact factor: 6.603

3.  The involvement of integrin β1 signaling in the migration and myofibroblastic differentiation of skin fibroblasts on anisotropic collagen-containing nanofibers.

Authors:  Chengyang Huang; Xiaoling Fu; Jie Liu; Yanmei Qi; Shaohua Li; Hongjun Wang
Journal:  Biomaterials       Date:  2011-12-02       Impact factor: 12.479

Review 4.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

5.  Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells.

Authors:  Emma Sandilands; Bryan Serrels; Simon Wilkinson; Margaret C Frame
Journal:  EMBO Rep       Date:  2012-06-26       Impact factor: 8.807

6.  Presenilin 1 affects focal adhesion site formation and cell force generation via c-Src transcriptional and posttranslational regulation.

Authors:  Dieter Waschbüsch; Simone Born; Verena Niediek; Norbert Kirchgessner; Irfan Y Tamboli; Jochen Walter; Rudolf Merkel; Bernd Hoffmann
Journal:  J Biol Chem       Date:  2009-01-27       Impact factor: 5.157

7.  Effects of VLA-1 Blockade on Experimental Inflammation in Mice.

Authors:  Ryuichi Totsuka; Takaaki Kondo; Shigeki Matsubara; Midori Hirai; Yoichi Kurebayashi
Journal:  Kobe J Med Sci       Date:  2016-07-05

8.  The focal complex of epithelial cells provides a signalling platform for interleukin-8 induction in response to bacterial pathogens.

Authors:  Tyson P Eucker; Derrick R Samuelson; Mary Hunzicker-Dunn; Michael E Konkel
Journal:  Cell Microbiol       Date:  2014-06-02       Impact factor: 3.715

9.  GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.

Authors:  Gidi Shani; Wolfgang H Fischer; Nicholas J Justice; Jonathan A Kelber; Wylie Vale; Peter C Gray
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

Review 10.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.